| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 4 | |
| #2 | WIPO (World Intellectual Property Organization) | 3 | |
| #3 | Australia | 2 | |
| #4 | Canada | 2 | |
| #5 | EPO (European Patent Office) | 2 | |
| #6 | China | 1 | |
| #7 | Norway | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Heterocyclic compounds | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations |
| # | Name | Total Patents |
|---|---|---|
| #1 | Fernandes Prabhavathi B | 8 |
| #2 | Nichols David Earl | 6 |
| #3 | Wikstrom Hakan | 6 |
| #4 | Dijkstra Durk | 6 |
| #5 | Mailman Richard Bernard | 6 |
| #6 | Postlethwait Robert Neil | 4 |
| #7 | Mailman Richard B | 2 |
| #8 | Nichols David E | 2 |
| #9 | Postlethwait Robert N | 1 |
| #10 | Postlethwait Robert Niel | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2006012640A2 | Method of administration of dopamine receptor agonists | |
| CN1964713A | Co-administration of dopamine-receptor binding compounds | |
| AU2003217430A1 | Mono-ester and asymmetrically substituted Di-ester pro-drugs of the dopamine D1 receptor agonists |